Monoclonal antibody therapies are restricted to qualifying persons. You must have tested COVID positive, and have a qualifying health condition. The assessment below will screen you to see if you are eligible for a monoclonal antibody therapy. If you qualify, you will be directed to our online scheduler.
ARE YOU ELIGIBLE FOR THIS THERAPY?
Please Read & Agree
Please make every effort to arrive at your designated appointment time. If you arrive more than 10 minutes early you may be asked to wait in your vehicle until your appointment time. If you are more than 15 minutes late, we may have to reschedule your appointment if we are not able to accommodate you at the time you arrive.
Family is not permitted to stay in the building during your appointment. There are circumstances in which individuals will need to be accompanied by family or caregiver, those situations will be assessed at the discretion of our clinical staff. Children under the age of 12 or children not being treated are not permitted to come with you to your appointment.
EFFECTIVE JANUARY 1, 2022 – CARES ACT FUNDS HAVE RUN OUT
RELATED TO RECENT CHANGES IN GOVERNMENT FUNDING FOR COVID-19, WE ARE NO LONGER ABLE TO ACCEPT INSURANCE FOR MONOCLONAL ANTIBODY TREATMENT.
THERE WILL BE A $350 ADMINISTRATION FEE THAT MEDICARE HAS SET AS A BASIS FOR PROVIDERS. THIS FEE IS FOR ALL PATIENTS AND IS DUE AT THE TIME OF YOUR APPOINTMENT. WE ACCEPT CASH, DEBIT CARDS, DISCOVER, VISA AND MASTERCARD. WE WILL PROVIDE A DETAILED RECEIPT OF SERVICES FOR YOU TO SUBMIT TO YOUR INSURANCE COMPANY FOR REIMBURSEMENT. WE CAN NOT GUARANTEE THAT YOUR INSURANCE PROVIDER WILL REIMBURSE YOUR PAYMENT.
WE APOLOGIZE FOR THE INCONVENIENCE AS WE NAVIGATE THROUGH THESE CHALLENGES.
Olympus infusions is currently providing bebtelovimab – the only currently EUA approved monoclonal antibody for the treatment of COVID-19. Guidelines for bebtelovimab can be found here: https://pi.lilly.com/eua/bebtelovimab-eua-factsheet-hcp.pdf
Olympus infusions is also providing Evusheld – a 6 month prophylactic monoclonal antibody for immune compromised patients. Guidelines for Evusheld can be found here: https://www.fda.gov/media/154701/download
Before making an appointment Olympus Infusions recommends that you inform your primary care physician if you have tested positive for COVID-19, or have been in direct contact with someone that has. You and your doctor can then make an informed decision regarding receiving a monoclonal antibody infusion. We also recommend following up with your PCP after receiving the therapy, and letting them know how you are feeling.
Please visit the FAQs tab for all of the information you will need to know prior to your appointment.
